She said the committee recommended using vaccines based on messenger RNA technology - such as those developed by Pfizer and Moderna - in people over 80, but did not say whether that ruled out the use of the AstraZeneca drug in such patients.
That number for Niagara will be different than what Niagara Region Public Health releases at noon, due to a difference in when the data is collected. On Monday, 1,969 new cases were recorded and 1,848 on Sunday. According to OPH's COVID-19 dashboard, Ottawa received 4,875 additional doses of vaccine on Monday. Once sufficient doses are available, vaccinations will resume to provide first doses for staff and essential caregivers in settings with the most vulnerable populations.
Deaths fell below the 21-day average of 73. They also said 21 more people died from the disease. "The longest lag that I've observed so far is about four weeks", between reported cases and COVID-19 deaths, said Aaron Wendelboe, an epidemiologist at the University of Oklahoma College of Public Health.
As of Saturday, the province had confirmed 57 cases of the United Kingdom variant, with infections reported in new regions including Halton and Waterloo. Approximately 300 additional cases were also included in Toronto's count the previous day, due to a "data catch-up". There are 241 active outbreaks at long-term care homes, 142 at retirement homes and 89 at hospitals.
The numbers are very small, but Novavax said they suggest the vaccine is almost 96% effective against the older coronavirus and almost 86% effective against the new variant . "Consistent with recent reports of the neutralization of variant SARS-CoV-2 or corresponding pseudoviruses by convalescent or post-immunization sera, neutralization against the virus with the three key mutations present in the South African variant (E484K+N501Y+D614G) was slightly lower when compared to neutralization of ...
The Philippines will receive 5,500,800 to 9,290,400 doses of AstraZeneca vaccines. Ontario Premier Doug Ford put pressure on Health Canada to approve other vaccines , including Johnson & Johnson's and AstraZeneca's candidates, telling reporters on Thursday that additional vaccines would be needed to cover the Pfizer shortfall, slamming the U.S.